$INVX

Innovex International, Inc. (INVX): Unregistered Sales of Equity Securities

Innovex International, Inc. (INVX) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. 8-K 0001042893 false 0001042893 2026-06-15 2026-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15 ,

Original reporting
Published Jun 15, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 11:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$INVX
Bullish
medium confidence
Mentioned
$INVX
Relevance
5/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INVXBullishMed
01

Why it matters

Traders can underwrite the deal’s valuation using the disclosed purchase price, consideration structure, expected closing timing, and management’s stated accretion/ROCE metrics; watch for deal-arbitrage flows and any subsequent amendments/closing updates.

02

Market read

A newly disclosed SEC filing provides concrete M&A terms (price, consideration mix, lock-up, and stated accretion/ROCE) that can move INVX expectations ahead of the expected Q3 close.

03

What to watch

Stock consideration is priced off prior 15-trading-day NYSE VWAP and the seller’s shares are lock-up restricted for six months, which can affect near-term supply/demand dynamics and deal arbitrage behavior.

Relevance 5/10Novelty 8/10Timing: Filed June 15, 2026; closing expected early Q3 2026.

Background

The 8-K explains Innovex’s Share Purchase Agreement to acquire TCO Group AS from Rieber & Søn AS, with consideration split between newly issued INVX shares and cash.

Company-level read

Ticker impact

$INVXBullishMedium confidence
Context

Innovex filed an 8-K for its planned ~$95M acquisition of TCO Group, including $30M in newly issued INVX shares and $65M cash.

Expected impact

Likely supportive bias if investors view the acquisition as accretive, but stock may face volatility around deal mechanics (stock issuance/lock-up) until closing.

Evidence & confidence

The filing discloses purchase price, consideration structure, expected closing window, and stated EPS accretion/ROCE, which are direct inputs to deal valuation and near-term sentiment.

Market effects

Could modestly signal consolidation/strategic investment in oil-and-gas downhole equipment/services suppliers.

Limited direct regional impact; transaction is cross-border (Norway private seller) but affects a US-listed acquirer.

Adds to global M&A activity in energy services equipment; may influence peer deal expectations at the margin.

Counterpoint

Accretion/ROCE are calculated using 2025 standalone figures and do not reflect integration costs, synergies, or other charges that could reduce realized returns.

Key entities

  • Innovex International, Inc.

    US-listed acquirer (INVX) filing the 8-K for the TCO Group acquisition.

  • TCO Group AS

    Norwegian oil-and-gas downhole equipment/services company being acquired.

  • Rieber & Søn AS

    Norwegian private seller under the Share Purchase Agreement.

Related articles

Med

Innovex International, Inc. Q2 2026 Earnings Call Summary

Innovex International, Inc. reported Q2 progress driven by higher international activity and subsea momentum, aided by integration of Dril-Quip and cross-selling. It acquired TCO Group, expecting Q3 2026 revenue of $15M and EBITDA of $3M from TCO. Middle East air freight added a $1.5M margin headwind. TCO was funded with $65M cash and $30M stock.

$INVXMed

Innovex International, Inc. (INVX): Results of Operations and Financial Condition

Innovex International, Inc. (INVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 invx-ex99_1.htm EX-99.1 EX-99.1 Innovex Announces Second Quarter 2026 Results HOUSTON, August 3, 2026 – Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the second quarter of 2026. Second Qua

$INVXMed

Innovex buys TCO Group in $95m deal

Innovex International completed its acquisition of TCO Group in a cash-and-stock deal valued at $95m, according to Innovex. The company says the purchase should be accretive to EPS, improve returns over time, and expand global sales of TCO’s glass barrier technologies via Innovex’s commercial platform, including Norway and the UAE.

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.